EAM
GBT
EULAV Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-380,000
| Closed | -$12.1M | – | 207 |
|
|
2022
Q2 | $12.1M | Sell |
380,000
-45,000
| -11% | -$1.44M | 0.5% | 61 |
|
|
2022
Q1 | $14.7M | Sell |
425,000
-75,000
| -15% | -$2.6M | 0.44% | 69 |
|
|
2021
Q4 | $14.6M | Buy |
500,000
+50,000
| +11% | +$1.46M | 0.37% | 81 |
|
|
2021
Q3 | $11.5M | Buy |
450,000
+40,000
| +10% | +$1.02M | 0.3% | 97 |
|
|
2021
Q2 | $14.4M | Buy |
410,000
+65,000
| +19% | +$2.28M | 0.38% | 92 |
|
|
2021
Q1 | $14.1M | Buy |
345,000
+25,000
| +8% | +$1.02M | 0.38% | 89 |
|
|
2020
Q4 | $13.9M | Buy |
+320,000
| New | +$13.9M | 0.36% | 92 |
|